ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 2256

Histopathologic Features and Tissue Interferon-Response Gene Scoring of Lesional Skin Samples for Diagnosis in Autoinflammatory Disorders

Kyawt W. Shwin1,2, Chyi-Chia Richard Lee3, Adriana Almeida de Jesus4, Carmelo Carmona-Rivera5, Louise Malle4, Yanfeng Hou6, Gina A. Montealegre Sanchez4, Edward Cowen7 and Raphaela Goldbach-Mansky8, 1Translational Autoinflammatory Diseases Studies, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, 2National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 3Dermatopathology Section, Laboratory of Pathology, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, 4National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, 5Systemic Autoimmunity Branch/ NIAMS, National Institutes of Health, Bethesda, MD, 6Translational Autoinflammatory Disease Studies, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, 7Dermatology Branch, National Cancer Institute (NCI), National Institutes of Health, Bethesda, MD, 8Translational Autoinflammatory Disease Studies, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: Autoinflammatory Disease, IL-1, Immune Dysregulation, interferons and vasculitis

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Innate Immunity and Rheumatic Disease - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Many genetically defined autoinflammatory diseases (AID) are caused by innate immune dysregulation and present with “neutrophilic dermatoses”. This study systematically assesses immune-cell infiltrates, and interferon (IFN) scores in skin biopsies of 2 IFN-mediated AID: STING-Associated Vasculopathy with onset in Infancy (SAVI) and Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature (CANDLE) and 2 IL-1-mediated AID, Neonatal-onset Multisystem Inflammatory Disease (NOMID) and Deficiency of IL-1 Receptor Antagonist (DIRA). We hypothesize that histopathologic and immunologic features present in skin lesions can distinguish IFN- from IL-1-mediated disorders.

Methods: Tissue from skin lesions of patients with NOMID (n=4), DIRA (n=4), SAVI (n=3), CANDLE (n=5) and other interferonopathies (UIFN) (n=7) were stained with H&E. Immunohistochemistry with antibodies to Myeloperoxidase (MPO/Neutrophil), CD163 (macrophage), CD123 (plasmacytoid dendritic cell (pDC)), CD3 (T cell), CD19 (B cells) was performed. The presence of Neutrophil extracellular traps (NETs, citrullinated histone H4) and IFN-inducible protein (Mx1) were assessed by immunofluorescence. An RNA IFN score was obtained. Inflammatory cells in skin regions were semi-quantitatively scored: 0=absent, 1=scant, 2=moderate or 3=abundant.

Results:

Clinically, NOMID patients present with urticaria, DIRA with pustulosis, CANDLE with nodular rashes and SAVI with acral violaceous vasculitic plaques. Histochemically, dense MPO+ cells within intraepidermal microabscesses were seen only in DIRA. In CANDLE, MPO+ and CD163+ cells were noted predominantly in the deep dermis and sucutis. SAVI had intravascular thrombi, fibrinoid necrosis of vascular wall with abundant perivascular MPO+ and CD163+ cells. Nuclear debris was seen in SAVI and CANDLE. Mild CD123+ cells were seen in dermis and perivascular areas in SAVI and CANDLE; but not in DIRA and rarely in one NOMID sample. CD3+ cells were seen predominantly in dermis and perivascular areas in SAVI, and in periadnexal areas in CANDLE. Dermal CD19+ cells were noted only in a patient with long-standing SAVI. The presence of NETs was evident in NOMID, DIRA and CANDLE, but not in SAVI. SAVI and CANDLE samples have positive Mx-1 staining and high IFN-response gene scores, but not in NOMID and DIRA.

Conclusion: A distinct histologic pattern of neutrophil and macrophage infiltration characterizes SAVI, CANDLE, NOMID and DIRA skin biopsies, while Mx-1 staining and the IFN score distinguish IFN- and IL-1 mediated AID. Thus, the histologic and immunologic assessment of skin biopsies may guide the diagnosis and identify dysregulated immune pathways in AID. Furthermore the skin can serve as a tissue model to evaluate molecular pathways that lead to the skin manifestations in genetically defined and undefined inflammatory diseases.


Disclosure: K. W. Shwin, None; C. C. R. Lee, None; A. Almeida de Jesus, None; C. Carmona-Rivera, None; L. Malle, None; Y. Hou, None; G. A. Montealegre Sanchez, None; E. Cowen, None; R. Goldbach-Mansky, None.

To cite this abstract in AMA style:

Shwin KW, Lee CCR, Almeida de Jesus A, Carmona-Rivera C, Malle L, Hou Y, Montealegre Sanchez GA, Cowen E, Goldbach-Mansky R. Histopathologic Features and Tissue Interferon-Response Gene Scoring of Lesional Skin Samples for Diagnosis in Autoinflammatory Disorders [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/histopathologic-features-and-tissue-interferon-response-gene-scoring-of-lesional-skin-samples-for-diagnosis-in-autoinflammatory-disorders/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2016

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histopathologic-features-and-tissue-interferon-response-gene-scoring-of-lesional-skin-samples-for-diagnosis-in-autoinflammatory-disorders/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology